M&A Deal Summary

Agilitas Private Equity Acquires Frontier Medical Group

On June 2, 2021, private equity firm Agilitas Private Equity acquired medical products company Frontier Medical Group from Kester Capital

Acquisition Highlights
  • This is Agilitas Private Equity’s 1st transaction in the Medical Products sector.
  • This is Agilitas Private Equity’s 5th transaction in the United Kingdom.

M&A Deal Summary

Date 2021-06-02
Target Frontier Medical Group
Sector Medical Products
Buyer(s) Agilitas Private Equity
Sellers(s) Kester Capital
Deal Type Secondary Buyout

Target

Frontier Medical Group

Tredegar, United Kingdom
Frontier Medical is a diversified medical devices business focused on the Skin/Wound Care and Infection Prevention markets. The business’ Skin/Wound Care brands include Repose®, Toto® and DermisPlus® which are used in the prevention and treatment of pressure ulcers (bed sores) and treatment of wounds. Frontier Medical Group was founded in 1966 and is based in Tredegar, United Kingdom.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

DESCRIPTION

Agilitas Private Equity is a private investment group focused on acquiring European businesses exhibiting significant barriers to entry, long-term customer relationships, and differentiated resources. Agilitas will consider businesses with complex business models or transaction structures. Agilitas Private Equity was established in 2011 and is based in London.


DEAL STATS #
Overall 11 of 15
Sector (Medical Products) 1 of 1
Type (Secondary Buyout) 3 of 3
Country (United Kingdom) 5 of 6
Year (2021) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-11-01 Exemplar Health Care

Rotherham, United Kingdom

Exemplar Health Care provides person-centered, specialist nursing care, offering support to individuals in the UK living with complex physical and mental health needs, where the quality of care is paramount. The company’s homes, which are based across Yorkshire, Humberside, the Midlands, the North East, and the North West, focus on improving the lives of adults living with mental health conditions, neuro-disabilities, complex dementia, autism, and learning disabilities, as well as those suffering from brain injury, spinal injury, and stroke. It provides customized, person-centered nursing care facilitates therapeutic engagement and aims to succeed where other care providers have failed. Exemplar Health Care was formed in 2003 and is based in Rotherham.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-01 Prodieco Advanced Engineering Solutions

Tallaght, Ireland

Prodieco Advanced Engineering Solutions engages in designing, manufacturing, and supplying bespoke precision blister tooling change parts for blister packaging lines for pharmaceutical, animal and consumer health market products globally. Prodieco Advanced Engineering Solutions was founded in 1962 and is based in Tallaght, Ireland.

Buy -

Seller(S) 1

DESCRIPTION

Kester Capital is a private equity firm focused on middle-market company investments in the UK. The Firm looks to invest a minimum of £5 million in businesses valued up to £100 million. Kester Capital was originally established in 2007 as Greenhill Capital Partners Europe, the European private equity arm of Greenhill & Co Inc. Kester Capital is based in London.


DEAL STATS #
Overall 6 of 10
Sector (Medical Products) 1 of 2
Type (Secondary Buyout) 2 of 6
Country (United Kingdom) 3 of 6
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-08 Optibrium

Cambridge, United Kingdom

Optibrium is a drug discovery software provider to the pharmaceutical and biotech industries. The market for computer aided drug discovery (CADD) is valued at >£2 billion and is projected to grow at double digit rates in the medium term. Its StarDrop product is a complete platform of integrated software for small molecule design, optimisation and data analysis that enhances the speed and productivity of the drug discovery process. Optibrium’s recently launched Cerella product uses artificial intelligence to learn from complex drug discovery data to target high-potential chemical compounds. The business’ customer base includes five of the top ten global pharmaceutical companies.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-15 Rephine

Stevenage, United Kingdom

Rephine is a provider of Good Manufacturing/Clinical Practice (GMP/GCP) audits and regulatory consulting services to the pharmaceutical industry. Headquartered in Stevenage, and with offices in India and Turkey, Rephine is a business that has pioneered a differentiated approach to GMP/GCP auditing through its audit library model.

Buy -